Ledger.Open graph →
SEC Form D · filed August 1, 2025

D&D Pharmatech Inc

Offering
$10.8M
Sold
$10.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SEONGNAM-SI, M5
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Seungwon Lim · Seongnam-si, M5DirectorSeulki Lee · Baltimore, MDExec · DirectorSungmook Lim · Seongnam-si, M5Exec · DirectorDaehyun Shin · Seongnam-si, M5DirectorSeol-Heui Han · Seongnam-si, M5DirectorSunghoon Hong · Seongnam-si, M5Exec · DirectorSeulki Lee · Baltimore, MDExec · DirectorSungmook Lim · Seongnam-si, M5Exec · DirectorDaehyun Shin · Seongnam-si, M5DirectorSeol-Heui Han · Seongnam-si, M5DirectorSeungwon Lim · Seongnam-si, M5DirectorSunghoon Hong · Seongnam-si, M5Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗